» Articles » PMID: 16170597

Effect of Charge and Molecular Weight on Transdermal Peptide Delivery by Iontophoresis

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2005 Sep 20
PMID 16170597
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The study was conducted to investigate the impact of charge and molecular weight (MW) on the iontophoretic delivery of a series of dipeptides.

Methods: Constant current iontophoresis of lysine and 10 variously charged lysine- and tyrosine-containing dipeptides was performed in vitro.

Results: Increasing MW was compensated by additional charge; for example, Lys (MW = 147 Da, +1) and H-Lys-Lys-OH (MW = 275 Da, +2) had equivalent steady-state fluxes of 225 +/- 48 and 218 +/- 40 nmol cm(-2) h(-1), respectively. For peptides with similar MW, e.g., H-Tyr-D-Arg-OH (MW = 337 Da, +1) and H-Tyr-D-Arg-NH(2) (MW = 336 Da, +2), the higher valence ion displayed greater flux (150 +/- 26 vs. 237 +/- 35 nmol cm(-2) h(-1)). Hydrolysis of dipeptides with unblocked N-terminal residues, after passage through the stratum corneum, suggested the involvement of aminopeptidases. The iontophoretic flux of zwitterionic dipeptides was less than that of acetaminophen and dependent on pH.

Conclusions: For the series of dipeptides studied, flux is linearly correlated to the charge/MW ratio. Data for zwitterionic peptides indicate that they do not behave as neutral ("charge-less") molecules, but that their iontophoretic transport is dependent on the relative extents of ionization of the constituent ionizable groups, which may also be affected by neighboring amino acids.

Citing Articles

Strategies for transportation of peptides across the skin for treatment of multiple diseases.

Bhavsar J, Kasture K, Salvi B, Shende P Ther Deliv. 2024; 16(1):63-86.

PMID: 39411995 PMC: 11703487. DOI: 10.1080/20415990.2024.2411943.


Non-Invasive Delivery of Negatively Charged Nanobodies by Anodal Iontophoresis: When Electroosmosis Dominates Electromigration.

Sahraoui P, Vadas O, Kalia Y Pharmaceutics. 2024; 16(4).

PMID: 38675200 PMC: 11055110. DOI: 10.3390/pharmaceutics16040539.


Iontophoresis application for drug delivery in high resistivity membranes: nails and teeth.

Martins Andrade J, da Cunha Miranda T, Cunha-Filho M, Taveira S, Gelfuso G, Gratieri T Drug Deliv Transl Res. 2022; 13(5):1272-1287.

PMID: 36209312 DOI: 10.1007/s13346-022-01244-0.


Anti-inflammatory ethosomal nanoformulation in combination with iontophoresis in chronic wound healing: An ex vivo study.

Mombeiny R, Tavakol S, Kazemi M, Mehdizadeh M, Hasanzadeh A, Karimi Babaahmadi M IET Nanobiotechnol. 2021; 15(9):710-718.

PMID: 34694760 PMC: 8806119. DOI: 10.1049/nbt2.12069.


The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye.

Wang L, Zhou M, Zhang H Ophthalmol Ther. 2021; 10(3):465-494.

PMID: 34218424 PMC: 8319259. DOI: 10.1007/s40123-021-00365-y.


References
1.
Kalia Y, Naik A, Garrison J, Guy R . Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004; 56(5):619-58. DOI: 10.1016/j.addr.2003.10.026. View

2.
Suzuki Y, Iga K, Yanai S, Matsumoto Y, Kawase M, Fukuda T . Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1-34). J Pharm Pharmacol. 2001; 53(9):1227-34. DOI: 10.1211/0022357011776676. View

3.
Chang J, Knecht R, Braun D . A complete separation of dimethylaminoazobenzenesulphonyl-amino acids. Amino acid analysis with low nanogram amounts of polypeptide with dimethylaminoazobenzenesulphonyl chloride. Biochem J. 1982; 203(3):803-6. PMC: 1158301. DOI: 10.1042/bj2030803. View

4.
Nakamura K, Katagai K, Mori K, Higo N, Sato S, Yamamoto K . Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats. Int J Pharm. 2001; 218(1-2):93-102. DOI: 10.1016/s0378-5173(01)00615-9. View

5.
Lee K, Fitch C, Lecomte J, Garcia-Moreno E B . Electrostatic effects in highly charged proteins: salt sensitivity of pKa values of histidines in staphylococcal nuclease. Biochemistry. 2002; 41(17):5656-67. DOI: 10.1021/bi0119417. View